Genetics

Researchers have engineered bacteria to create a “living medicine” against a nasty respiratory bug.

After a monumental year of breakthroughs, scientists, investors, and CEOs share which areas of biotech they are eagerly watching this year.

Microproteins encoded in short strands of DNA reveal our recent evolutionary history, and hint at how human genetics may be changing.

A new hypothesis suggests that Alzheimer's disease is the result of "jumping genes" in the brain, not inflammation or plaque.

Researchers have resurrected an ancient CRISPR system 2.6 billion years old, capable of editing genes in the modern day.

Biotech startup Rejuvenate Bio says it has extended the lives of elderly mice by 7% using a technique called “partial reprogramming.”

A new therapy that treats children with rare mtDNA mutations using mitochondria sourced from their mothers has now been tested in patients.

A dog's breed has a big impact on their personality, but whether they fit your lifestyle is also down to good training.

A new multiple myeloma therapy that uses an antibody to bring T cells to the cancer has shown efficacy in clinical trials.

Neoplants' $179 genetically engineered houseplant pulls VOCs from the air 30 times more efficiently than plants found in nature.